Samantha Greissman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Samantha Greissman has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Adela Mattiazzi
Division of Nephrology and Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, FL, USA
1 shared publicationAngela Dimango
Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University Irving Medical Center, New York, New York
1 shared publicationBryan Stanifer
Department of Surgery, Columbia University Irving Medical Center, New York, New York
1 shared publicationFrank D’-Ovidio
Department of Surgery, Columbia University Irving Medical Center, New York, New York
1 shared publication- Gabriela Magda
Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University Irving Medical Center, New York, New York
1 shared publication Giselle Guerra
Division of Nephrology and Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, FL, USA
1 shared publication
Latest Publications
- 7 November 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (4) , 480-487
Lung transplant waitlist outcomes among ABO blood groups vary based on disease severity
- 7 November 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (4) , 480-487
Lung transplant waitlist outcomes among ABO blood groups vary based on disease severity
- 26 May 2020
- Published by Wiley in Transplant Infectious Disease
- Vol. 22 (4) , e13337
Antimicrobial resistance and recurrent bacterial urinary tract infections in hospitalized patients following kidney transplantation: A single‐center experience
Purpose: The burden of urinary tract infections (UTIs) and risk factors for developing infections with multidrug resistant organisms (MDROs) post‐kidney transplantation (KT) are poorly understood.Methods: Single‐center retrospective cohort study (January 2015‐December 2017) evaluating first and recurrent episodes of bacteriuria and subsequent analysis of episodes caused by MDROs up to 6 months post‐KT. Donor and recipient variables were reviewed.Results: A total of 743 adults underwent single KT during the study period, and 106 patients were hospitalized with bacteriuria. 45% were asymptomatic in their first episode. 73.6% had a single episode, and 26.4% had 2 or more episodes. A total of 28 patients had recurrent episodes; 64.3% had an MDRO on the first episode and 78.6% on the second episode. Escherichia coli was the most common organism isolated, 88.5% were resistant to trimethoprim‐sulfamethoxazole (TMP‐SMX), 9.3% were extended‐spectrum beta‐lactamase (ESBL) producers, and 38.1% were MDROs. Body mass index ≥30 was significantly associated with the presence of MDROs in both univariate and multivariate analyses (RR 1.37, 95% CI 1.01‐1.88; OR 3.26, CI 1.29‐8.25). A total of 12 donors had bacteremia or bacteriuria and 6 (50%) with E coli. A total of 10 KT recipients received antibiotic prophylaxis to prevent donor‐derived infections.Conclusions: Our results suggest that a significant proportion of patients develop recurrent bacteriuria post‐transplantation; of those, more than half caused by MDROs. There is a possible association between obesity and MDROs in KT recipients that merits further investigation. With the global crisis in antimicrobial resistance, innovative strategies are needed to prevent and treat UTIs in KT patients.
- 26 May 2020
- Published by Wiley in Transplant Infectious Disease
- Vol. 22 (4) , e13337
Antimicrobial resistance and recurrent bacterial urinary tract infections in hospitalized patients following kidney transplantation: A single‐center experience
Purpose: The burden of urinary tract infections (UTIs) and risk factors for developing infections with multidrug resistant organisms (MDROs) post‐kidney transplantation (KT) are poorly understood.Methods: Single‐center retrospective cohort study (January 2015‐December 2017) evaluating first and recurrent episodes of bacteriuria and subsequent analysis of episodes caused by MDROs up to 6 months post‐KT. Donor and recipient variables were reviewed.Results: A total of 743 adults underwent single KT during the study period, and 106 patients were hospitalized with bacteriuria. 45% were asymptomatic in their first episode. 73.6% had a single episode, and 26.4% had 2 or more episodes. A total of 28 patients had recurrent episodes; 64.3% had an MDRO on the first episode and 78.6% on the second episode. Escherichia coli was the most common organism isolated, 88.5% were resistant to trimethoprim‐sulfamethoxazole (TMP‐SMX), 9.3% were extended‐spectrum beta‐lactamase (ESBL) producers, and 38.1% were MDROs. Body mass index ≥30 was significantly associated with the presence of MDROs in both univariate and multivariate analyses (RR 1.37, 95% CI 1.01‐1.88; OR 3.26, CI 1.29‐8.25). A total of 12 donors had bacteremia or bacteriuria and 6 (50%) with E coli. A total of 10 KT recipients received antibiotic prophylaxis to prevent donor‐derived infections.Conclusions: Our results suggest that a significant proportion of patients develop recurrent bacteriuria post‐transplantation; of those, more than half caused by MDROs. There is a possible association between obesity and MDROs in KT recipients that merits further investigation. With the global crisis in antimicrobial resistance, innovative strategies are needed to prevent and treat UTIs in KT patients.